These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 26016766)

  • 1. Successful treatment of gynaecological involvement of granulomatosis with polyangiitis (Wegener's granulomatosis) by rituximab.
    Bastone P; Squifflet JL; Marbaix E; Houssiau F
    Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-142-4. PubMed ID: 26016766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab (MABTHERA) and severe polyangiitis. An option for patients informed of the uncertainties.
    Prescrire Int; 2015 Jun; 24(161):145-8. PubMed ID: 26436161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wegener's granulomatosis effectively treated with rituximab: a case study.
    Kowalewska B; Szechiński J; Roszkowska E
    Pol Arch Med Wewn; 2008 Jun; 118(6):381-5. PubMed ID: 18619196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab as a new therapeutic option in granulomatosis with polyangiitis: a report of two cases.
    Dalkilic E; Alkis N; Kamali S
    Mod Rheumatol; 2012 Jun; 22(3):463-6. PubMed ID: 21847703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab with or without a conventional maintenance agent in the treatment of relapsing granulomatosis with polyangiitis (Wegener's): a retrospective single-center study.
    Azar L; Springer J; Langford CA; Hoffman GS
    Arthritis Rheumatol; 2014 Oct; 66(10):2862-70. PubMed ID: 24943239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory pituitary granulomatosis with polyangiitis (Wegener's) treated with rituximab.
    Hughes J; Barkhoudarian G; Ciarlini P; Laws ER; Mody E; Inzucchi SE; Woodmansee WW
    Endocr Pract; 2013; 19(1):e1-7. PubMed ID: 23186961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab and leflunomide for Wegener's granulomatosis: a long-term follow-up.
    Henes JC; Kanz L; Koetter I
    Rheumatol Int; 2011 Mar; 31(3):425-6. PubMed ID: 20349065
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of granulomatosis with polyangiitis (Wegener's).
    Pagnoux C; Guillevin L
    Expert Rev Clin Immunol; 2015 Mar; 11(3):339-48. PubMed ID: 25644677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener's granulomatosis: a case report.
    Ooka S; Maeda A; Ito H; Omata M; Yamada H; Ozaki S
    Mod Rheumatol; 2009; 19(1):80-3. PubMed ID: 18806927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L25. Medical treatment of subglottic stenosis in granulomatosis with polyangiitis (Wegener's).
    Monach PA
    Presse Med; 2013 Apr; 42(4 Pt 2):575-6. PubMed ID: 23453209
    [No Abstract]   [Full Text] [Related]  

  • 11. Does Concomitant Methotrexate During Rituximab Treatment in Granulomatosis With Polyangiitis (Wegener's) Increase the Risk of Severe Infection? Comment on the Article by Azar et al.
    Besada E; Diamantopoulos AP
    Arthritis Rheumatol; 2015 Jul; 67(7):1981-2. PubMed ID: 25892609
    [No Abstract]   [Full Text] [Related]  

  • 12. Refractory Wegener's granulomatosis presenting with alveolar haemorrhage, treated with rituximab.
    Caetano J; Fernandes das Neves M; Oliveira S; Delgado Alves J
    BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25519869
    [No Abstract]   [Full Text] [Related]  

  • 13. Advances in the therapy of Wegener's granulomatosis.
    Hellmich B; Lamprecht P; Gross WL
    Curr Opin Rheumatol; 2006 Jan; 18(1):25-32. PubMed ID: 16344616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab for treatment-resistant extensive Wegener's granulomatosis--additive effects of a maintenance treatment with leflunomide.
    Henes JC; Fritz J; Koch S; Klein R; Horger M; Risler T; Kanz L; Koetter I
    Clin Rheumatol; 2007 Oct; 26(10):1711-5. PubMed ID: 17502992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab therapy for Wegener's granulomatosis refractory to conventional treatment.
    Sánchez-Escuredo A; Núñez R; Ibernón M; Martínez E; López D; Navarro M; Bonet J; Ara J; Romero R
    Nefrologia; 2011; 31(4):502-4. PubMed ID: 21738261
    [No Abstract]   [Full Text] [Related]  

  • 16. Rituximab induced remission in a patient with Wegener's granulomatosis.
    Kallenbach M; Duan H; Ring T
    Nephron Clin Pract; 2005; 99(3):c92-6. PubMed ID: 15665552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory Wegener's granulomatosis: effect of rituximab on granulomatous bilateral orbital involvement.
    Avshovich N; Boulman N; Slobodin G; Zeina AR; Rosner I; Rozenbaum M
    Isr Med Assoc J; 2009 Sep; 11(9):566-8. PubMed ID: 19960854
    [No Abstract]   [Full Text] [Related]  

  • 18. Macular oedema following rituximab infusion in two patients with Wegener's granulomatosis.
    Bussone G; Kaswin G; de Menthon M; Delair E; Brézin AP; Guillevin L
    Clin Exp Rheumatol; 2010; 28(1 Suppl 57):90-2. PubMed ID: 20412711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.
    Calich AL; Puéchal X; Pugnet G; London J; Terrier B; Charles P; Mouthon L; Guillevin L;
    J Autoimmun; 2014 May; 50():135-41. PubMed ID: 24703438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of orbital inflammation with rituximab in Wegener's granulomatosis.
    Baslund B; Wiencke AK; Rasmussen N; Faurschou M; Toft PB
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S7-10. PubMed ID: 22272561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.